Page last updated: 2024-10-24

celecoxib and Aggressive Systemic Mastocytosis

celecoxib has been researched along with Aggressive Systemic Mastocytosis in 1 studies

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moreno-Borque, R1
Matito, A1
Álvarez-Twose, I1
Morgado, JM1
Sánchez-Muñoz, L1
Orfao, A1
Escribano, L1

Other Studies

1 other study available for celecoxib and Aggressive Systemic Mastocytosis

ArticleYear
Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2015, Volume: 115, Issue:5

    Topics: Celecoxib; Cyclooxygenase 2 Inhibitors; Diarrhea; Female; Humans; Mastocytosis, Systemic; Middle Age

2015